ZHAO Yu-Dan, ZHANG Xin, YANG Wan-Yue, ZHANG Rui-Qi, MU Lin-Tong, HAN Ling, LV Chong-Ning, LU Jin-Cai. New anti-pulmonary fibrosis prenylflavonoid glycosides from Epimedium koreanum [J].Chin J Nat Med, 2022, 20(3): 221-228. DOI: 10.1016/S1875-5364(21)60116-4
Citation: ZHAO Yu-Dan, ZHANG Xin, YANG Wan-Yue, ZHANG Rui-Qi, MU Lin-Tong, HAN Ling, LV Chong-Ning, LU Jin-Cai. New anti-pulmonary fibrosis prenylflavonoid glycosides from Epimedium koreanum [J].Chin J Nat Med, 2022, 20(3): 221-228. DOI: 10.1016/S1875-5364(21)60116-4

New anti-pulmonary fibrosis prenylflavonoid glycosides from Epimedium koreanum

  • Four new prenylflavonoid glycosides, namely koreanoside H–K ( 14 ), together with eleven known ones ( 515 ) were isolated from the leaves of Epimedium koreanum Nakai. Their structures were elucidated by 1D NMR, 2D NMR, HR-ESI-MS, IR and UV. The identification of the sugar moieties was carried out by means of acid hydrolysis and HPLC analysis of their derivatives. It is worth noting that compound 3 and compound 4 were elucidated to contain fucose and quinovose moieties, which were two extremely rare sugar units from the genus Epimedium. The anti-pulmonary fibrosis activity of the new compounds was evaluated using A549 cell line. Compounds 1 , 2 and 4 showed significant anti-pulmonary fibrosis activities.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return